|
British Columbia
|
Not applicable
|
|
|
(State or other jurisdiction of incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
|
Large accelerated filer
|
☒
|
Accelerated filer
|
☐ | |
|
Non-accelerated filer
|
☐
|
Smaller reporting company
|
☐ | |
|
Emerging growth company
|
☐ |
|
Item 8.
|
Exhibits.
|
|
Exhibit
No. |
|
Description
|
|
|
Form of Articles of the Registrant (Incorporated by reference to Exhibit 3.3 to the Registrant’s Registration Statement on Form S-1, as amended (File No. 333-250838)).
|
|
|
|
Amended and Restated Investors’ Rights Agreement among the registrant and certain of its shareholders, dated March 23, 2020 (Incorporated by reference to Exhibit 4.1 to the registrant’s Registration Statement
on Form S-1, as amended (File No. 333-250838)).
|
|
|
|
Opinion of Blake, Cassels & Graydon LLP.
|
|
|
|
Consent of KPMG LLP, Independent Registered Public Accounting Firm.
|
|
|
|
Consent of Armanino LLP, Independent Registered Public Accounting Firm.
|
|
|
|
Consent of Blake, Cassels & Graydon LLP (included in Exhibit 5.1).
|
|
|
|
Power of Attorney (included on signature page to this registration statement).
|
|
|
|
2020 Share Option and Incentive Plan and forms of award agreements thereunder (Incorporated by reference to Exhibit 10.13 to the registrant’s Registration Statement on Form S-1, as amended (File
No. 333-250838)).
|
|
|
Unaudited Pro Forma Condensed Combined Financial Information
|
||
|
Financial Statements of Trianni, Inc. (Acquired Company)
|
||
|
Filing Fee Table
|
||
|
*
|
Filed herewith.
|
|
ABCELLERA BIOLOGICS INC.
|
||
|
|
||
|
By:
|
/s/ Carl L. G. Hansen
|
|
|
Carl L. G. Hansen, Ph.D.
|
||
|
Chief Executive Officer
|
||
|
Signature
|
|
Title
|
|
Date
|
|
/s/ Carl L. G. Hansen
|
|
Chief Executive Officer and Director
|
|
February 25, 2022
|
| Carl L. G. Hansen, Ph.D. | (Principal Executive Officer) | |||
|
/s/ Andrew Booth
|
|
Chief Financial Officer
|
|
February 25, 2022
|
| Andrew Booth | (Principal Financial Officer and Principal Accounting Officer) | |||
|
/s/ Véronique Lecault, Ph.D.
|
|
Chief Operating Officer and Director
|
|
February 25, 2022
|
| Véronique Lecault, Ph.D. | ||||
|
/s/ Michael Hayden, Ph.D.
|
|
Director
|
|
February 25, 2022
|
| Michael Hayden, Ph.D. | ||||
|
/s/ Andrew W. Lo, Ph.D.
|
Director
|
February 25, 2022
|
||
|
Andrew W. Lo, Ph.D.
|
||||
|
/s/ John S. Montalbano
|
|
Director
|
|
February 25, 2022
|
| John S. Montalbano | ||||
|
/s/ Peter Thiel
|
Director
|
February 25, 2022
|
||
|
Peter Thiel
|
||||
|
/s/ Tryn Stimart
|
Authorized Representative in the United States
|
February 25, 2022
|
||
|
Tryn Stimart
|
||||
|
|
|
|||